Search icon

SIGA TECHNOLOGIES, INC.

Company Details

Name: SIGA TECHNOLOGIES, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 28 Mar 1996 (29 years ago)
Entity Number: 2014583
ZIP code: 12207
County: New York
Place of Formation: Delaware
Principal Address: 31 East 62nd Street, 5th floor, NEW YORK, NY, United States, 10065
Address: 80 STATE STREET, ALBANY, NY, United States, 12207

Agent

Name Role Address
CORPORATION SERVICE COMPANY Agent 80 STATE STREET, ALBANY, NY, 12207

DOS Process Agent

Name Role Address
C/O CORPORATION SERVICE COMPANY DOS Process Agent 80 STATE STREET, ALBANY, NY, United States, 12207

Chief Executive Officer

Name Role Address
DIEM NGUYEN Chief Executive Officer 31 EAST 62ND STREET, 5TH FLOOR, NEW YORK, NY, United States, 10065

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
1V4X4
Status:
Active
Type:
U.S./Canada Manufacturer
CAGE Update Date:
2024-06-06
CAGE Expiration:
2029-06-06
SAM Expiration:
2025-06-04

Contact Information

POC:
DANIEL J.. LUCKSHIRE
Phone:
+1 212-672-9100
Fax:
+1 212-697-3130

Form 5500 Series

Employer Identification Number (EIN):
133864870
Plan Year:
2016
Number Of Participants:
48
Sponsors Telephone Number:
Plan Year:
2015
Number Of Participants:
54
Sponsors Telephone Number:
Plan Year:
2014
Number Of Participants:
56
Sponsors Telephone Number:
Plan Year:
2013
Number Of Participants:
84
Sponsors Telephone Number:
Plan Year:
2012
Number Of Participants:
73
Sponsors Telephone Number:

History

Start date End date Type Value
2024-06-18 2024-06-18 Address 680 MADISON AVENUE, SUITE 1700, NEW YORK, NY, 10065, USA (Type of address: Chief Executive Officer)
2024-06-18 2024-06-18 Address 31 EAST 62ND STREET, 5TH FLOOR, NEW YORK, NY, 10065, USA (Type of address: Chief Executive Officer)
2024-05-30 2024-06-18 Address 80 STATE STREET, ALBANY, NY, 12207, 2543, USA (Type of address: Service of Process)
2024-05-30 2024-06-18 Address 680 MADISON AVENUE, SUITE 1700, NEW YORK, NY, 10065, USA (Type of address: Chief Executive Officer)
2024-05-30 2024-06-18 Address 80 STATE STREET, ALBANY, NY, 12207, 2543, USA (Type of address: Registered Agent)

Filings

Filing Number Date Filed Type Effective Date
240618000271 2024-06-18 BIENNIAL STATEMENT 2024-06-18
240530019712 2024-05-29 CERTIFICATE OF CHANGE BY ENTITY 2024-05-29
160815002000 2016-08-15 BIENNIAL STATEMENT 2016-03-01
100407002070 2010-04-07 BIENNIAL STATEMENT 2010-03-01
080310003056 2008-03-10 BIENNIAL STATEMENT 2008-03-01

USAspending Awards / Contracts

Procurement Instrument Identifier:
W911SR24C0030
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
8999677.03
Base And Exercised Options Value:
8999677.03
Base And All Options Value:
8999677.03
Awarding Agency Name:
Department of Defense
Performance Start Date:
2024-08-02
Description:
PROCUREMENT OF 23,030 TPOXX ORAL COURSES AND 50 TPOXX IV COURSES. TO MAINTAIN NATIONAL STOCKPILE.
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS
Procurement Instrument Identifier:
W911SR22C0051
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
1091797.50
Base And Exercised Options Value:
1091797.50
Base And All Options Value:
1091797.50
Awarding Agency Name:
Department of Defense
Performance Start Date:
2022-09-28
Description:
TO DELIVER COURSES OF TPOXX TO REPLENISH THE NATIONAL STOCKPILE OF SMALLPOX TREATMENTS.
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS
Procurement Instrument Identifier:
W911SR22C0032
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
3834617.50
Base And Exercised Options Value:
3834617.50
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2022-05-12
Description:
EXERCISE OPTIONAL CLINS 0002 AND 0004 TO PROCURE ADDITIONAL DOSES (10,885) OF TPOXX (SMALLPOX ANTIVIRAL THERAPEUTIC AND SHIPPING.
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS

USAspending Awards / Financial Assistance

Date:
2011-08-17
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
ANTIVIRAL DRUGS FOR ARENAVIRUSES
Obligated Amount:
7105873.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2011-05-03
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
ANTIVIRAL THERAPEUTICS FOR FLAVIVIRUS INFECTIONS
Obligated Amount:
5805389.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2009-09-18
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
BROAD-SPECTRUM, SMALL-MOLECULE INHIBITORS OF BUNYAVIRUSES
Obligated Amount:
1667535.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2008-08-18
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
NOVEL SMALL MOLECULE INHIBITORS OF DENGUE REPLICATION
Obligated Amount:
963737.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2009-08-28
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
ST-246 TREATMENT OF SMALLPOX VACCINE-RELATED ADVERSE EVENTS
Obligated Amount:
2999939.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
86409876
Mark:
ZYGAVIM
Status:
ABANDONED - AFTER PUBLICATION
Mark Type:
TRADEMARK
Application Filing Date:
2014-09-30
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
ZYGAVIM

Goods And Services

For:
Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases
International Classes:
005 - Primary Class
Class Status:
Abandoned
Serial Number:
86409863
Mark:
TPOXX
Status:
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Mark Type:
TRADEMARK
Application Filing Date:
2014-09-30
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
TPOXX

Goods And Services

For:
Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases
First Use:
2016-06-13
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
85568561
Mark:
VARBLOCK
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2012-03-13
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
VARBLOCK

Goods And Services

For:
Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
85568516
Mark:
ARESTVYR
Status:
CANCELLED - SECTION 8
Mark Type:
TRADEMARK
Application Filing Date:
2012-03-13
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
ARESTVYR

Goods And Services

For:
Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases
First Use:
2014-01-14
International Classes:
005 - Primary Class
Class Status:
Sec. 8 – Entire Registration
Serial Number:
77977868
Mark:
SIGA
Status:
REGISTERED AND RENEWED
Mark Type:
TRADEMARK
Application Filing Date:
2007-09-21
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
SIGA

Goods And Services

For:
Pharmaceuticals and pharmaceutical preparations for the treatment of medical disorders, namely, infectious diseases, smallpox infections, bioterrorism and emerging disease agents and viral diseases
First Use:
2009-06-24
International Classes:
005 - Primary Class
Class Status:
Active

Date of last update: 14 Mar 2025

Sources: New York Secretary of State